Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl
CLP22001
Phase 1 other active
Quick answer
Bioequivalence of two transdermal therapeutic systems delivering 100 mcg/h fentanyl for Bioequivalence trial in healthy volunteers is a Phase 1 program (other) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharm Research Associates (UK) Limited
- Indication
- Bioequivalence trial in healthy volunteers
- Phase
- Phase 1
- Modality
- other
- Status
- active